These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20082322)

  • 1. Loss of syndecan-1 is associated with malignant conversion in skin carcinogenesis.
    Stepp MA; Pal-Ghosh S; Tadvalkar G; Rajjoub L; Jurjus RA; Gerdes M; Ryscavage A; Cataisson C; Shukla A; Yuspa SH
    Mol Carcinog; 2010 Apr; 49(4):363-73. PubMed ID: 20082322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta1 enhances tumor promotion in mouse skin carcinogenesis.
    Pérez-Lorenzo R; Markell LM; Hogan KA; Yuspa SH; Glick AB
    Carcinogenesis; 2010 Jun; 31(6):1116-23. PubMed ID: 20172950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary dermal fibroblasts derived from sdc-1 deficient mice migrate faster and have altered alphav integrin function.
    Jurjus RA; Liu Y; Pal-Ghosh S; Tadvalkar G; Stepp MA
    Wound Repair Regen; 2008; 16(5):649-60. PubMed ID: 19128260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant conversion, the first stage in progression, is distinct from phorbol ester promotion in mouse skin.
    Hennings H
    Basic Life Sci; 1991; 57():31-9; discussion 39-42. PubMed ID: 1814291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
    Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
    Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical retinoic acid reduces skin papilloma formation but resistant papillomas are at high risk for malignant conversion.
    Tennenbaum T; Lowry D; Darwiche N; Morgan DL; Gartsbein M; Hansen L; De Luca LM; Hennings H; Yuspa SH
    Cancer Res; 1998 Apr; 58(7):1435-43. PubMed ID: 9537245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
    Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
    Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion.
    Owens DM; Watt FM
    Cancer Res; 2001 Jul; 61(13):5248-54. PubMed ID: 11431366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratinocyte p38δ loss inhibits Ras-induced tumor formation, while systemic p38δ loss enhances skin inflammation in the early phase of chemical carcinogenesis in mouse skin.
    Kiss A; Koppel AC; Anders J; Cataisson C; Yuspa SH; Blumenberg M; Efimova T
    Mol Carcinog; 2016 May; 55(5):563-74. PubMed ID: 25753147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profile of skin papillomas with high cancer risk displays a unique genetic signature that clusters with squamous cell carcinomas and predicts risk for malignant conversion.
    Darwiche N; Ryscavage A; Perez-Lorenzo R; Wright L; Bae DS; Hennings H; Yuspa SH; Glick AB
    Oncogene; 2007 Oct; 26(48):6885-95. PubMed ID: 17525749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion.
    Glick AB; Kulkarni AB; Tennenbaum T; Hennings H; Flanders KC; O'Reilly M; Sporn MB; Karlsson S; Yuspa SH
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6076-80. PubMed ID: 7687059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis.
    Weinberg WC; Montano NE; Deng C
    Oncogene; 1997 Aug; 15(6):685-90. PubMed ID: 9264409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
    Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
    Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROCK2/ras
    Masre SF; Rath N; Olson MF; Greenhalgh DA
    Oncogene; 2017 May; 36(18):2529-2542. PubMed ID: 27991921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered regulation of TGF-beta 1 and TGF-alpha in primary keratinocytes and papillomas expressing v-Ha-ras.
    Glick AB; Sporn MB; Yuspa SH
    Mol Carcinog; 1991; 4(3):210-9. PubMed ID: 2064727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
    Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
    Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model.
    Vijayachandra K; Lee J; Glick AB
    Cancer Res; 2003 Jul; 63(13):3447-52. PubMed ID: 12839923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
    Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
    Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis.
    Tennenbaum T; Weiner AK; Belanger AJ; Glick AB; Hennings H; Yuspa SH
    Cancer Res; 1993 Oct; 53(20):4803-10. PubMed ID: 8402665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.